Kingworld Medicines Group (HKG:1110) expects to swing to losses in the first half of 2025, according to a Hong Kong bourse filing Thursday.
The company expects to report 4.5 million yuan in attributable loss, compared to 30.7 million yuan in profit a year earlier.
Kingworld's financial results are due Aug. 27.
Shares of the pharma distributor fell over 3% in late-morning trade Friday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.